Temporary Distribution Suspension Notification

Emergent Travel Health (ETH) has made the difficult decision to temporarily discontinue U.S. product distribution of VAXCHORA® (Cholera Vaccine, Live, Oral) and VIVOTIF® (Typhoid Vaccine Live Oral Ty21a) due to significant reduction in demand and following an assessment of data from a wide range of sources including government institutions, external research firms, and industry expert reports that point to a lengthy recovery period for international travel due to the COVID-19 pandemic.

With that said, we remain fully committed to travel health and seek to properly position ourselves for the return of global travel and our products to the market in the near future. To this end, you may sign up using the form below to receive ongoing communications and updates from Emergent Travel Health, Inc. as they become available.


We use cookies on this site (and other similar technologies)
to enhance your user experience.

You can manage your Privacy settings on our sites at any time

Thank you for accepting cookies.

You can now hide this message or select MANAGE PRIVACY to edit your privacy permissions at any time.

We use data collected by cookies and JavaScript libraries to improve your browsing experience, analyze site traffic, deliver personalized advertisements, and increase the overall performance of our sites.

You can manage your permissions for how we may use the data we collect using the settings below. These settings describe the current permissions we have enabled for you as a user of one of our sites. To change any permission, select YES to provide permission or NO to revoke or disallow permissions for any of the Categories or Purposes listed below.

For more information about how we handle personal information that you provide to us, you may access this site’s Privacy Policy at any time.

You can also SUPPRESS or DELETE any information you've shared with us at any time.